Clinical trial · Observational
Pulmonary Hypertension in Lymphangioleiomyomatosis
Observational Study of Patients With Lymphangioleiomyomatosis and Pulmonary Hypertension
NCT00960895CI-TRIAL-00005692LAM-PHcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a descriptive study of patients with Lymphangioleiomyomatosis and precapillary pulmonary hypertension.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphangioleiomyomatosis | Lymphangioleiomyomatosis | ONTOLOGY_EXACT | 0.98 |
| Pulmonary Hypertension | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Lymphangioleiomyomatosis (definite or probable), either sporadic or associated with tuberous sclerosis * Precapillary pulmonary hypertension, as defined by right-sided heart catheterization (mean pulmonary artery pressure higher than 25 mmHg, wedge capillary pulmonary pressure less than 15 mmHg, pulmonary vascular resistance higher than 3 Wood units) Exclusion Criteria: * Post capillary pulmonary hypertension * Other identifiable causes of pulmonary hypertension (ex: thromboembolic disease) * Not willing to participate
References
Publications (0)
Data not yet available
No reference posted for this study.